Objective: To assess anatomical and visual outcomes plus complications of surgeries in patients with stage 4
and 5 retinopathy of prematurity in a tertiary eye care centre in Bangladesh.
Methods: Retrospective case series of all patients that underwent surgery for stage 4 and 5 retinopathy of
prematurity between January 2015 and January 2018 was carried out. Anatomic outcomes, qualitative visual
acuity as well as the complications were assessed.
Results: Thirty three eyes of 25 patients were recruited in the study (12 male and 13 female). Overall 22 (66.7%)
of the eyes had complete retinal re-attachment. The percentage for complete re-attachment for stage 4A, 4B,
and 5 were 89.5%, 66.7% and 12.5% respectively. Overall 19 eyes (57.6%) had ability to fix and follow objects. This
included 14 eyes (73.7%) in stage 4A, 4 eyes (66.7%) in stage 4B and 2 eyes (25.0%) in stage 5. The commonest
complications noted were cataracts (15.2%), vitreous haemorrhage (15.2%) and glaucoma (9.1%).
Conclusion: Anatomical outcomes of surgery for stage 4A retinopathy of prematurity are very encouraging
while those of stage 4B and 5 are poorer. Consequently, visual outcomes for stage 4A are also better than those
for stage 4B and 5.
Asano MK, Papakostas TD, Palma CV, Skondra
D. Visual outcomes of surgery for stage 4 and 5
retinopathy of prematurity. Int Ophthalmol Clin. 2014;
Hartnett ME, Penn JS. Mechanisms and management
of retinopathy of prematurity. N Engl J Med. 2012;
Repka MX, Tung B, Good WV, Capone A, Shapiro
MJ. Outcome of eyes developing retinal detachment
during the early treatment for retinopathy of
prematurity study. Arch Ophthalmol. 2011;
Helen A, Kathleen A, Alice ZC. Efficacy of
intravitreal bevacizumab for stage 3+ retinopathy of
prematurity. N Engl J Med. 2011; 364(7):603–615.
Good WV. Final results of the Early Treatment for
Retinopathy of Prematurity (ETROP) randomized
trial. Trans Am Ophthalmol Soc. 2004; 102:233-250.
Gilmore JH. Surgical management of retinopathy of
prematurity. North. 2008; 29(10):1883–89.
Ramak R, Reza K, Mohammad RE, Fariba G, Mehdi NA, et
al. Surgical management in advanced stages of retinopathy
of prematurity; our experience. J Ophthalmic Vis Res. 2009;
Shah PK. Retinopathy of prematurity: Past, present
and future. World J Clin Pediatr [Internet]. 2016;
Lakhanpal RR, Sun RL, Albini TA, Coffee R, Coats
DK, et al. Visual outcomes after 3-port lens-sparing
vitrectomy in stage 4 retinopathy of prematurity. Arch
Ophthalmol. 2006; 124(5):675–679.
Article S. The International Classification of
Retinopathy of Prematurity Revisited. Arch
Ophthalmol [Internet]. 2005; 123(7):991.
Maguire AM, Treese MT. Lens-sparing vitrectomy
surgery in infants. Arch Ophthalmol. 1992; 110:284–286.
Capone A, Trese MT. Lens-sparing vitreous surgery
for tractional stage 4A retinopathy of prematurity
retinal detachments. Ophthalmology. 2001;
Ertzbischoff LM. A systematic review of anatomical
and visual function outcomes in preterm infants after
scleral buckle and vitrectomy for retinal detachment.
Adv Neonatal Care. 2004; 4:10–19.
Hubbard GB, Cherwick DH, Burian G. Lens-sparing
vitrectomy for stage 4 retinopathy of prematurity.
Ophthalmology. 2004; 111:2274–77.
El Rayes EN, Vinekar A, Capone A. Three-year
anatomic and visual outcomes after vitrectomy for
stage 4B retinopathy of prematurity. Retina. 2008;
Choi J, Kim JH, Kim S-J, Yu YS. Long-term results
of lens-sparing vitrectomy for stages 4B and 5
retinopathy of prematurity. Korean J Ophthalmol.
Hartnet ME. Features associated with surgical
outcome in patients with stages 4 and 5 retinopathy
of prematurity. Retina. 2003; 23:322–329.
Xu Y, Zhang Q, Kang X, Zhu Y, Li J, et al. Early
vitreoretinal surgery on vascularly active stage 4
retinopathy of prematurity through the preoperative
intravitreal bevacizumab injection. Acta Ophthalmol.